BackNewAmsterdam Pharma Company NV Overview

NewAmsterdam Pharma Company NV Current Assets

Track NewAmsterdam Pharma Company NV's current assets ($660M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$659.21M
↓ 14.37% YoYΔ $-110.64M vs prior year quarter

Peer trimmed avg / median

Loading

NewAmsterdam Pharma Company NV Current Assets History

Loading

NewAmsterdam Pharma Company NV vs. peers: Current Assets Comparison

Loading

NewAmsterdam Pharma Company NV Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NewAmsterdam Pharma Company NV (NAMS) FAQ

As of the most recent data (June 2026), NAMS shows a current assets of $660M. That compares with $770M in the prior-year period — down 14.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NAMS's current assets is now $660M (was $770M) — a 14.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether NewAmsterdam Pharma Company NV is outperforming or lagging.

Tracking NAMS's current assets over time shows whether NewAmsterdam Pharma Company NV is scaling, shrinking, or reshaping that part of the business. The current reading is $660M That compares with $770M in the prior-year period — down 14.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has NewAmsterdam Pharma Company NV's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $660M) with ownership activity and broader fundamentals.